Litcius/Paper detail

Tocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma

Frederick L. Locke, Sattva S. Neelapu, Nancy L. Bartlett, Lazaros J. Lekakis, Caron A. Jacobson, Ira Braunschweig, Olalekan O. Oluwole, Tanya Siddiqi, Yi Lin, John M. Timmerman, Marie José Kersten, Yan Zheng, Teresa Zhang, Jenny Nater, Rhine R. Shen, Harry Miao, Jenny Kim, David B. Miklos

2024Transplantation and Cellular Therapy27 citationsDOIOpen Access PDF

Topics & Concepts

MedicineRefractory (planetary science)TocilizumabLymphomaB-cell lymphomaOncologyInternal medicineMaterials scienceComposite materialDiseaseCAR-T cell therapy researchVirus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects
Tocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma | Litcius